Abstract 1980: Validation of a novel Type II HER2 inhibitor through preclinical studies across various cancer models

Authors: Lana Kulyk, Kelly Chen, Iriny Botrous, Chunmei Zhao, Chang Zhao, Michael Maestre, Shawn Wright, Joseph Dennis, Jeeyoung Park, Abby Adams, Wallace Derricotte, Shane Yost, Mary L. Anderson, Fred Manby, Tom Miller, Chao Zhang, Laurent Gomez, Zhongdong Huang

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-1980

Source: Full article